Dentsply Sirona (XRAY) has delivered lower merger synergies than the company had estimated. It also took an impairment charge during 4Q17.
With the recent transition in leadership at Dentsply Sirona (XRAY), the new team has laid out a robust strategic growth plan.
In 4Q17, Dentsply Sirona (XRAY) started reporting its operations under two segments, after a shift to three segments in fiscal 3Q17.
In October 2017, Dentsply Sirona implemented a series of management changes to position itself as a stronger and more efficient organization.
For 4Q17, Dentsply Sirona reported constant currency sales growth of ~5.3%, on a YoY (year-over-year) basis.
Dentsply Sirona (XRAY) updated its estimates and assumptions during fiscal 2Q17 and underwent an annual impairment test of goodwill.
On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.
Dentsply Sirona is a leading dental technology, equipment, and consumables provider in the US. But it has been going through some tough times.
SuperValu has been strategically focusing on positioning itself as a wholesaler.
SuperValu (SVU) announced on March 14 that it’s selling 21 of its 38 Farm Fresh stores to three grocery store chains.